Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506 by Francavilla, A et al.
Reprinted from HEPATOLOGY. st. Louis 
Vol. 14. No.1. PP. 140-143. July. 1991 (Printed in the U.S.A.) 
(Copyright 0 1991 by The American Association for the Study of Liver Diseases) 
Studies on Mechanisms of Augmentation of Liver 
Regeneration by Cyclosporine and FK 506 
ANTONIO FRANCAVILLA,4 THOMAS E. STARZL, 1 MICHELE BARONE,4 QI-HUA ZENG, 1 KENDRICK A. PORTER,5 
ADRIANNI ZEEVI,l PETER M. MARKUS,l MARCELL R.M. VAN DEN BRINK3 AND SATORU TODOl 
The Departments of ISurgery, 2Pathology and 3Neuroscience, University Health Center of Pittsburgh, University of 
Pittsburgh, Pittsburgh, Pennsylvania 15213; the 4Department of Gastroenterology, University of Bari, Bari 70100, Italy; and 
the 5Department of Pathology, Saint Mary's Hospital and Medical School, London W2, United Kingdom 
Evidence could not be found of immune modulation 
of liver regeneration. The powerful immunosup-
pressive drug FK 506, which augments the response 
after partial hepatectomy in normal rats, had the same 
effect in T cell-deficient nude rats. The cytotoxicity of 
natural killer cells in treated nude rats was not 
significantly changed by FK 506 therapy. However, the 
serum of FK 50S-treated nude rats increased hepa-
tocyte proliferation when added to third-party hepa-
tocyte cultures, suggesting that FK 506 had induced a 
serum growth factor in the nude rats or had suppressed 
an inhibitory factor. A hypothesis was advanced that 
FK 506 (and cyclosporine) affects hepatic growth by 
nonimmunological pathways. (HEPATOLOGY 1991;14:140-
143.) 
An unusual quality of two powerful immunosup-
pressive agents, FK 506 and cyclosporine, is augmen-
tation of the regeneration response after partial hepatic 
resection (1-4). Two alternate explanations have been 
advanced for this phenomenon, one of which is the 
altered immune modulation of the regeneration re-
sponse by these immunosuppressive agents that inhibit 
T-Iymphocyte activation (4). The alternate hypothesis is 
that these drugs influence growth control responses by 
nonimmunological pathways, involving as yet poorly 
understood second messenger processes, signal trans-
duction processes or both (4-6). 
In this study regeneration was studied in nude rats 
first, to see whether these T-Iymphocyte-deficient an-
imals had normal regeneration, and second, to de-
termine whether FK 506, which is a specific inhibitor of 
T-helper-Iymphocyte activation, augmented the regen-
eration response. Failure to do so would support the 
immune modulation hypothesis. In addition, natural 
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FIG. 1. [3H] thymidine incorporation and percentage of labeled 
hepatocyte nuclei 24 hr after 70% hepatectomy in nude (NIH-RNUJ 
rats treated (right) or not treated (left) with FK 506. Mean ± S.E.M. 
(p < 0.05* or < 0.01 **). Ten animals in each group. 
killer (NK) lymphocytes recently have been shown to 
have increased cytotoxicity against regenerating hepa-
tocytes (7). Consequently, the effect of FK 506 on NK 
lymphocytes was determined in unoperated nude rats. 
The results of both kinds of experiments provided no 
evidence that either lymphocyte subpopulation plays a 
role in the control of regeneration. 
METHODS 
In Vivo Experiments 
Male nude rats (NIH-RNU, National Cancer Institute, 
Frederick, MD) were kept in pathogen-free temperature-
controlled and light-controlled rooms and provided with food 
and water ad libitum. Before purchase, these rats were tested 
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FIG. 2. Lytic activity ofNK cells isolated from nude rats treated and 
untreated with FK 506. NK cells were added at a ratio of either 1: 100 
or 1: 200 to target lymphoma cells. Each bar = four experiments. 
Mean ± S.E.M. 
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FIG. 3. Effect on DNA synthesis of cultured hepatocytes of differenl 
concentrations of rat serum obtained from nude rats treated or nol 
treated with FK 506. n = 5 in both experiments. (p < 0.05* or 
< 0.01**). 
TABLE 1. Experimental groups 
Group No. rats Route 
1 10 1M 
2 10 1M 
3 4a 1M 
4 5a 1M 
aSerum and spleen were obtained at killing for in vitro experiments. 
1M = intramuscular. 
by the National Cancer Institute and found to have absent 
T-Iymphocytes and T-Iymphocyte-mediated function. The 
nude rats were assigned to the four groups as shown in Table 1. 
The 70% hepatectomies in groups 1 and 2 were performed 
with the rats under methopfane anesthesia between 7:30 and 
9:00 AM by the method of Higgins and Anderson (8). Intra-
muscular drugs or saline vehicle was given daily during the 
three days before the surgery and just after completion of the 
operation. A further dose was given 24 hr after operation, 2 hr 
before killing. At the same time as the final dose, 50 mCi l3H - ] 
thymidine/200 gm body wt was administered intraperito-
neally. Liver DNA synthesis was judged by the incorporation 
of [3H - ] thymidine and by the percent of labeled hepatocyte 
nuclei as previously described (4). The mortality rate was zero 
in treated and untreated groups. 
In Vitro Experiments 
NK Cell Activity. In nude rats of groups 3 and 4 that had not 
been subjected to operation, the spleens were removed under 
sterile conditions at the time of death and NK cell preparations 
were made (9). Single cell suspensions prepared in RPMI 1640 
in 5% FCS by this technique have viability exceeding 97% by 
trypan blue exclusion. These cells were tested for their ability 
to lyse the NK-sensitive Moloney virus-induced mouse T-cell 
FK Vehicle Liver resection 
0 Saline 70% 
1 mg/kg Saline 70% 
0 Saline o (no operation) 
1 mglkg Saline o (no operation) 
lymphoma YAC-1. The target tumor cell lines were grown in 
RPMI 1640 medium with 5% FCS and penicillin/streptomycin 
and subcultured two to three times per week until used. 
The cytotoxicity of the NK cells was measured with a 
standard [51Cr]-release assay after labeling the target cells 
with 100 mCi ofNa2 51Cr04/2 x 106 cells. NK cells were added 
to triplicate well round-bottom microplates (Costar, Cam-
bridge, MA) that contained constant numbers of target cells to 
give an effector/target cell ratio of 1: 100 or 1: 200. After 
incubation at 37° C for 4 hr, the activity of the supernatant was 
determined in a gamma counter. Spontaneous isotope release 
(control) was obtained from wells receiving target cells and 
medium only, and total isotope release was obtained from wells 
receiving 1% Triton X-I00 (Sigma Chemical Co., St. Louis, 
MO). The percent of cytotoxicity was calculated by: Percent 
cytotoxicity = 100 x [(Experimental release - Spontaneous 
release)/(Total release - Spontaneous release)]. 
Serum Stimulatory Activity. Sera at death were obtained 
from the FK 506-treated and untreated nonoperated nude rats 
in groups 3 and 4 and assayed for their hepatocyte stimulatory 
qualities. Target hepatocytes were isolated from 7-wk-old 
Fischer (F344) rats that weighed 180 to 200 gm. A modification 
of the two-step perfusion technique ofSeglen (10) was used as 
described by Jirtle et al. (11). Viability was determined by 
trypan blue exclusion, and hepatocytes counted by hemocy-
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tometer were plated at a cell density of 1.5 x 105 /well using 1.5 
ml MEM + 5% FCS and 10- 7 molar insulin at 37° C in a 5% 
CO2 atmosphere. Hepatocyte DNA synthesis was determined 
with [3H - ] thymidine incorporation (4,5). Serum or cellular 
proteins were determined by the method of Lowry et al. (12). 
Statistical Analysis. Data were presented as mean:': S.E.M. 
Unpaired Student's t test was used for statistical analysis of 
the data. 
RESULTS 
In Vivo Experiments 
The nude rats not treated with FK 506 had a 16-fold 
increase in DNA synthesis and a commensurate increase 
of autographically labeled hepatocyte nuclei (Fig. 1). The 
regeneration response by both parameters was signifi-
cantly greater when the animals received the 5-day 
course of preoperative treatment with FK 506 (Fig. 1). 
In Vitro Experiments 
NK Cell Activity. The splenic NK cell cytolytic activity 
was vigorous when the cells were added at an effective 
target ratio of 100 : 1 or 200: 1. This cytolytic activity was 
neither increased nor decreased by a 5-day course of FK 
506 (Fig. 2), findings similar to those reported by 
Markus et al. (13) in normal Fischer rats. 
Hepatocyte Stimulatory Factors in Serum. The serum 
of vehicle-treated unoperated nude rats (group 3) caused 
slight stimulation of F344 hepatocytes in culture (Fig. 
3), an effect of normal rat serum that is well known 
(5, 14). 
In contrast, the serum of unoperated nude rats 
submitted to a 5-day course of FK 506 (group 14) 
significantly increased the rate of replication when 
added to the hepatocyte culture medium. This was 
significant at all of the higher volume serum enrich-
ments (Fig. 3). This stimulatory effect of the rat sera 
from FK 506-treated nude rats was similar to that 
previously seen in operated immunologically competent 
Fischer rats treated with FK 506 (5). 
DISCUSSION 
These experiments suggest but do not prove that T 
helper or NK lymphocytes are unimportant in con-
trolling liver regeneration, contrary to the speculation in 
the literature summarized elsewhere (4, 5, 7). In the 
nude rats in which the T cells were not present, the 
regeneration response was normal. Nevertheless, the 
FK 506, which targets T cells for its immunological 
action (15), augmented regeneration in the same way as 
in immunologically intact animals. The additional pos-
sibility (7) that NK cells were defunctionalized by the 
immunosuppressive therapy was essentially eliminated 
by our in vitro experiments and by in vivo experiments 
reported elsewhere (13). 
Instead, the evidence, although circumstantial, is 
congruent with our previously enunciated hepatotrophic 
hypothesis that FK 506 and cyclosporine (16) affect 
basic growth control mechanisms that are independent 
of immunological pathways. Both FK 506 and cyclo-
sporine have cytosolic binding sites that, although 
distinct, contain peptidyl-prolyl isomerase (17, 18), an 
enzyme that facilitates the breakdown of oligopeptide 
bonds and facilitates protein folding (19). Cellular 
growth regulation as epitomized by its hepatotrophic 
qualities (6, 16; Francavilla A, Starzl TE, Porter K, et al. 
Manuscript submitted for publication, 1991), includ-
ing regeneration (4, 5), is only one of the nonimmuno-
logical pleiotropic effects (20) of this ubiquitous immu-
nophilin network after it binds FK 506 or cyclospor-
ine (21). 
The intriguing observation in our current experi-
ments was the apparent development of hepatocyte 
stimulatory activity in the serum of FK 506-treated 
nude rats. The finding was similar to that recently 
reported in immunologically competent Fischer rats 
treated with this drug (5). At the moment, no clue exists 
as to the explanation for this induced stimulatory 
activity. The possibility has not been ruled out that what 
actually occurred instead of stimulation was removal or 
suppression of an inhibitory factor. 
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